The Dow Is Soaring Because Russia Approved a Covid-19 Vaccine and Other Dubious Assertions

Deutschland Nachrichten Nachrichten

The Dow Is Soaring Because Russia Approved a Covid-19 Vaccine and Other Dubious Assertions
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 70 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 97%

Russia’s approval of a coronavirus vaccine is being given credit for the big bounce in U.S. stocks. But there’s more going on than the headline suggests.

9:59 a.m. The Dow Jones Industrial Average is soaring after Russia announced that it had approved a Covid-19 vaccine.

The Dow has gained 337 points, or 1.2%, while the S&P 500 has risen 0.4%, and the Nasdaq Composite has declined 0.4%. The S&P 500’s rise puts the index closer to an all-time high. Of course, Russia’s announcement shouldn't be taken at face value. In fact, it’s not even an approval, at least not as the term would be used in the U.S. ”In a televised meeting, Russian President, Vladimir Putin, stated that Moscow’s Gamaleya Institute successfully developed a ‘safe and effective’ coronavirus vaccine ready to move to a Phase 3 trial, sparking risk-on money flows,” writes The Sevens Reports Tom Essaye.

Of course, by that standard, a number of U.S. vaccines would have already been approved as well. If the Russia vaccine is the catalyst for the stock market’s move this morning, it’s likely because it further catalyzed a narrative that is already in place: New coronavirus cases are declining in the U.S., earnings have been better than expected, and investors, with plenty of Fed liquidity at their backs, want to own something other than big tech. A proposal by U.S.

“I’m not entirely sure that’s what the economy needs right now, or the public purse for that matter, but with Trump going into the election on the back foot as a result of the pandemic, rising record stock markets are one thing he has going for him,” writes Oanda’s Craig Erlam.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

MarketWatch /  🏆 3. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Russia unveils first COVID-19 vaccineRussia unveils first COVID-19 vaccineRussia registered the world’s first Covid-19 vaccine, President Vladimir Putin said,
Weiterlesen »

WHO says discussing new COVID-19 vaccine with RussiaWHO says discussing new COVID-19 vaccine with RussiaThe World Health Organization (WHO) and Russian health authorities are discussing the process for possible WHO prequalification for its newly approved COVID-19 vaccine, a WHO spokesman said on Tuesday.
Weiterlesen »

Russia becomes first country to approve a COVID-19 vaccine, says PutinRussia becomes first country to approve a COVID-19 vaccine, says PutinPresident Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess. Regulatory approval paves the way for the mass
Weiterlesen »

Coronavirus updates: Russia becomes 1st country to approve COVID-19 vaccine, Putin's daughter given itCoronavirus updates: Russia becomes 1st country to approve COVID-19 vaccine, Putin's daughter given itCORONAVIRUS LATEST: • Russia becomes first country to approve COVID-19 vaccine, Putin says. • New Zealand returns to lockdown after finding local transmission. • U.S. records under 50,000 new cases for second straight day.
Weiterlesen »

Russia Has Approved World’s First Covid-19 Vaccine, Putin SaysRussia Has Approved World’s First Covid-19 Vaccine, Putin SaysRegulatory approval for the Russian vaccine comes before final trials are complete, raising concerns about its safety and efficacy.
Weiterlesen »

Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 detailsSinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 detailsChina's Sinovac Biotech Ltd launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
Weiterlesen »



Render Time: 2025-03-22 22:32:03